The role of chloride channels on cyclophosphamide-induced overactive bladder in rats

The role of chloride channels on cyclophosphamide-induced overactive bladder in rats

Bibliographic Details
Main Authors:	Yuh-Chen Kuo, Ju-Ton Hseih, Hann-Chorng Kuo
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2016-06-01
Series:	Urological Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S1879522616301464

Similar Items

Chloride channels are involved in the regulation of bladder smooth muscle tone in rats.
by: Yuh-Chen Kuo, et al.
Published: (2015-06-01)

Individualizing medical treatment of overactive bladder
by: Hann-Chorng Kuo
Published: (2018-01-01)

Treatment of overactive bladder: Past, present, and future
by: Hann-Chorng Kuo
Published: (2015-03-01)

Adverse Events of Intravesical Onabotulinum Toxin A Injection between Patients with Overactive Bladder and Interstitial Cystitis—Different Mechanisms of Action of Botox on Bladder Dysfunction?
by: Yuh-Chen Kuo, et al.
Published: (2016-03-01)

Low-Dose Cyclophosphamide Induces Nerve Injury and Functional Overactivity in the Urinary Bladder of Rats
by: Rui Wang, et al.
Published: (2021-10-01)

Effects of Tamsulosin on Urinary Bladder Function and Neuronal Activity in the Voiding Centers of Rats with Cyclophosphamide-induced Overactive Bladder
by: Sung-Eun Kim, et al.
Published: (2012-03-01)

Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis
by: Jing-Liang Chen, et al.
Published: (2020-02-01)

Practical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder Syndrome
by: Chun-Hou Liao, et al.
Published: (2015-12-01)

The Overactive Bladder Symptom Score, International Prostate Symptom Score–Storage Subscore, and Urgency Severity Score in Patients With Overactive Bladder and Hypersensitive Bladder: Which Scoring System is Best?
by: Fei-Chi Chuang, et al.
Published: (2018-06-01)

Recurrent urinary tract infection in women and overactive bladder – Is there a relationship?
by: Qian-Sheng Ke, et al.
Published: (2021-01-01)

Will repeated botulinum toxin A improve detrusor overactivity and bladder compliance in patients with chronic spinal cord injury?
by: Sheng-Fu Chen, et al.
Published: (2021-01-01)

Effects of ba-wei-die-huang-wan on cyclophosphamide-induced ongoing bladder overactivity and acidic atp solution-induced provoking of bladder overactivity
by: Wei-Chia Lee, et al.
Published: (2015-06-01)

Ablation of CHOP aggravates cyclophosphamide induced bladder overactivity by regulating macrophage apoptosis
by: J. Xiao, et al.
Published: (2020-07-01)

Astragalus polysaccharides and astragaloside IV ameliorates cyclophosphamide-induced mouse model of overactive bladder
by: Yung-Hsiang Chen, et al.
Published: (2020-03-01)

Factors associated with antimuscarinic drug persistence and increasing drug persistence after switching to mirabegron for overactive bladder patients
by: Chung-Cheng Wang, et al.
Published: (2019-01-01)

Reduction of urgency severity is the most important factor in the subjective therapeutic outcome of intravesical onabotulinumtoxina injection for overactive bladder
by: Jia-Fong Jhang, et al.
Published: (2015-12-01)

Development and validation of the Chinese Overactive Bladder Symptom Score for assessing overactive bladder syndrome in a RESORT study
by: Man-Jung Hung, et al.
Published: (2013-05-01)

Urinary Nerve Growth Factor Levels in Overactive Bladder Syndrome and Lower Urinary Tract Disorders
by: Hsin-Tzu Liu, et al.
Published: (2010-12-01)

Mirabegron escalation to 50 mg further improves daily urgency and urgency urinary incontinence in Asian patients with overactive bladder
by: Chun-Hou Liao, et al.
Published: (2019-03-01)

Factors Associated with Therapeutic Efficacy of Intravesical OnabotulinumtoxinA Injection for Overactive Bladder Syndrome.
by: Sheng-Mou Hsiao, et al.
Published: (2016-01-01)

The translation and validation of Chinese overactive bladder symptom score for assessing overactive bladder syndrome and response to solifenacin treatment
by: Eric Chieh-Lung Chou, et al.
Published: (2014-08-01)

The Pharmacological Mechanism of Diabetes Mellitus-Associated Overactive Bladder and Its Treatment with Botulinum Toxin A
by: Chung-Cheng Wang, et al.
Published: (2020-03-01)

Clinical guidelines for male lower urinary tract symptoms associated with non-neurogenic overactive bladder
by: Chung-Cheng Wang, et al.
Published: (2015-03-01)

Increased serum adipokines implicate chronic inflammation in the pathogenesis of overactive bladder syndrome refractory to antimuscarinic therapy.
by: Hsin-Tzu Liu, et al.
Published: (2013-01-01)

Efficacy and safety of intravesical onabotulinumtoxinA injection on elderly patients with chronic central nervous system lesions and overactive bladder.
by: Yuan-Hong Jiang, et al.
Published: (2014-01-01)

Duration of Antimuscarinic Administration for Treatment of Overactive Bladder Before Which One Can Assess Efficacy: An Analysis of Predictive Factors
by: Sheng-Mou Hsiao, et al.
Published: (2015-09-01)

O’Leary-Sant Symptom Index Predicts the Treatment Outcome for OnabotulinumtoxinA Injections for Refractory Interstitial Cystitis/Bladder Pain Syndrome
by: Yuh-Chen Kuo, et al.
Published: (2015-07-01)

Erratum to “Development and Validation of the Chinese Overactive Bladder Symptom Score for Assessing Overactive Bladder Syndrome in a RESORT Study” [Journal of the Formosan Medical Association 112/5 (2013) 276–282]
by: Man-Jung Hung, et al.
Published: (2013-06-01)

Safety and efficacy of botulinum toxin a treatment for patients with detrusor overactivity and inadequate contractility
by: Shu-Yu Wu, et al.
Published: (2015-12-01)

Presence of Cleaved Synaptosomal-Associated Protein-25 and Decrease of Purinergic Receptors P2X3 in the Bladder Urothelium Influence Efficacy of Botulinum Toxin Treatment for Overactive Bladder Syndrome.
by: Hsin-Tzu Liu, et al.
Published: (2015-01-01)

Urine biomarkers in ESSIC type 2 interstitial cystitis/bladder pain syndrome and overactive bladder with developing a novel diagnostic algorithm
by: Yuan-Hong Jiang, et al.
Published: (2021-01-01)

The overactive bladder
by: Richard Foon, et al.
Published: (2010-08-01)

Overactive bladder
by: Anna Zwierzyńska
Published: (2021-07-01)

Therapeutic outcome and patient adherence to repeated onabotulinumtoxinA detrusor injections in chronic spinal cord-injured patients and neurogenic detrusor overactivity
by: Sheng-Fu Chen, et al.
Published: (2015-07-01)

Overactive bladder induces transient hypertension
by: Kazumasa Torimoto, et al.
Published: (2018-03-01)

Role of serum immunoglobulin E in patients with interstitial cystitis/bladder pain syndrome
by: Jia-Fong Jhang, et al.
Published: (2015-09-01)

Expression of Caveolin-1 in Rat Urinary Bladder with Cyclophosphamide-Induced Cystitis
by: Sun-Ouck Kim, et al.
Published: (2012-12-01)

Overactive Bladder in Children
by: Rhaiana Gondim Oliveira, et al.
Published: (2018-06-01)

Overactive bladder in males
by: Alex Gomelsky, et al.
Published: (2009-10-01)

Postmenopausal overactive bladder
by: Jacek Tomaszewski
Published: (2014-12-01)

Cannot write session to /tmp/vufind_sessions/sess_folaiakuhq2so1vgdkg8m49jh7